The House Ways and Means Oversight Subcommittee today held a hearing focused on the Centers for Medicare & Medicaid Services’ efforts to use data to identify Medicare Part D beneficiaries who are at risk of misusing opioids. The hearing also examined the tools CMS has available to limit overprescribing. Witnesses were Kimberly Brandt, CMS principal deputy administrator for operations; Gary Cantrell, deputy inspector general for investigations at the Department of Health and Human Services’ Office of Inspector General; and Elizabeth Curda, director of health care at the Government Accountability Office. In addition, the Senate Committee on Homeland Security and Governmental Affairs today examined Medicaid and the opioid epidemic. Witnesses were Sam Adolphsen, senior fellow at the Foundation for Government Accountability; Otto Schalk, prosecuting attorney for Harrison County, IN; Emmanuel Tyndall, inspector general of Tennessee; David Hyman, M.D., of the Georgetown University Law Center; and Andrew Kolodny, M.D., co-director of opioid policy research at Brandeis University.

Related News Articles

Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and…
Headline
Eligible organizations can apply through May 6 for up to $1 million each for a three-year period to expand opioid and other substance use disorder services in…
Insights and Analysis
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.